Skip to content
Trial Eligibility
Menu

Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation

NCT03721822

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called [18F]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Smoking, Cigarette
  • Smoking E-cigarette
  • Healthy Volunteer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 45 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Pennsylvania
Last updated on ClinicalTrials.gov
September 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.